Amelioration of diabetic nephropathy by oral administration of d-α-tocopherol and its mechanisms

References

• Valmadrid CT, Klein R, Moss SE, et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 2000;160:1093–1100.10.1001/archinte.160.8.1093
   PubMed Web of Science ®Google Scholar
• Williams B, Gallacher B, Patel H, et al. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes. 1997;46:1497–1503.10.2337/diab.46.9.1497
   PubMed Web of Science ®Google Scholar
• Ruan X, Arendshorst WJ. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol. 1996;270:945–952.
   Web of Science ®Google Scholar
• Berne C. The metabolism of lipids in mouse pancreatic islets, the biosynthesis of triacylglycerols and phospholipids. Biochem J. 1975;152:667–673.10.1042/bj1520667
   PubMed Web of Science ®Google Scholar
• Dunlop ME, Larkins RG. Pancreatic islets synthesize phospholipids de novo from glucose via acyl-dihydroxyacetone phosphate. Biochem Biophys Res Commun. 1985;132:467–473.10.1016/0006-291X(85)91157-X
   PubMed Web of Science ®Google Scholar
• Craven AP, Davidson CM, DeRubertis FR. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes. 1990;47:667–674.10.2337/diab.39.6.667
   Google Scholar
• Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998;47:859–866.10.2337/diabetes.47.6.859
   PubMed Web of Science ®Google Scholar
• Shiba T, Inoguchi T, Sportsman JR, et al. Correlation of diacylglycerol and protein kinase C activity in rat retina to retinal circulation. Am J Physiol. 1993;136:1339–1348.
   Google Scholar
• Inoguchi T, Battan R, Handler E, et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA. 1992;89:11059–11063.10.1073/pnas.89.22.11059
   PubMed Web of Science ®Google Scholar
• Jones David R, Sanjuan Miguel A, Mérida Isabel. Type Iα phosphatidylinositol 4-phosphate 5-kinase is a putative target for increased intracellular phosphatidic acid. FEBS Lett. 2000;476:160–165.10.1016/S0014-5793(00)01702-6
   PubMed Web of Science ®Google Scholar
• Fang Y, Vilella-Bach M, Bachmann R, et al. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science. 2001;30:1942–1945.10.1126/science.1066015
   Web of Science ®Google Scholar
• Takai Y, Kishimoto A, Kikkawa U, et al. Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid dependent protein kinase system. Biochem Biophys Res Commun. 1979;91:1218–1224.10.1016/0006-291X(79)91197-5
   PubMed Web of Science ®Google Scholar
• Koya D, Lee IK, Ishii H, et al. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alphaTocopherol. J Am Soc Nephrol. 1997;8:426–435.
   PubMed Web of Science ®Google Scholar
• Topham MK, Prescott SM. Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions. J Biol Chem. 1999;274:11447–11450.10.1074/jbc.274.17.11447
   PubMed Web of Science ®Google Scholar
• van Blitterswijk WJ, Brahim H. Properties and functions of diacylglycerol kinases. Cell Signal. 2000;12:595–605.10.1016/S0898-6568(00)00113-3
   PubMed Web of Science ®Google Scholar
• Kanoh H, Yamada K, Sakane F. Diacylglycerol kinases: emerging downstream regulators in cell signaling systems. J Biochem. 2002;131:629–633.10.1093/oxfordjournals.jbchem.a003144
   PubMed Web of Science ®Google Scholar
• Fukunaga-Takenaka R, Shirai Y, Yagi K, et al. Importance of chroman ring and tyrosine phosphorylation in the subtype-specific translocation and activation of diacylglycerol kinase α by d-α-tocopherol. Genes Cell. 2005;10:311–319.10.1111/gtc.2005.10.issue-4
   PubMed Web of Science ®Google Scholar
• Hayashi D, Yagi K, Song, C, et al. Diacylglycerol kinase α is involved in the vitamin E-induced amelioration of diabetic nephropathy in mice. Sci Rep. 2017;7:2597.10.1038/s41598-017-02354-3
   PubMed Web of Science ®Google Scholar
• Mundel P, Kriz W. Structure and function of podocytes: an update. Anat Embryol. 1995;192:385–397.
   PubMedGoogle Scholar
• Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–348.10.1172/JCI119163
   PubMed Web of Science ®Google Scholar
• Kang N, Alexander G, Park JK, et al. Differential expression of protein kinase C isoforms in streptozotocin induced diabetic rats. Kidney Int. 1999;56(5):1737–1750.10.1046/j.1523-1755.1999.00725.x
   PubMed Web of Science ®Google Scholar
• Menne J, Park JK, Boehne M, et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase Calpha-deficient diabetic mice. Diabetes. 2004;53(8):2101–2109.10.2337/diabetes.53.8.2101
   PubMed Web of Science ®Google Scholar
• Quack I, Woznowski M, Potthoff SA, et al. PKCα mediates β-arrestin2-dependent nephrin endocytosis in hyperglycemia. J Cell Biol. 2011;286:12959–12970.
   Google Scholar
• Ishii H, Jirousek MR, Koya D, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science. 1996;272:728–731.10.1126/science.272.5262.728
   PubMed Web of Science ®Google Scholar
• Suzuki D, Miyata T, Saotome N, et al. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol. 1999;10:822–832.
   PubMed Web of Science ®Google Scholar
• Koya D, Hayashi K, Kitada M, et al. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol. 2003;14:S250–S253.10.1097/01.ASN.0000077412.07578.44
   PubMed Web of Science ®Google Scholar
• Ruotsalainen V, Ljungberg P, Wartiovaara J, et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA. 1999;96:7962–7967.10.1073/pnas.96.14.7962
   PubMed Web of Science ®Google Scholar
• Holthofer H, Ahola H, Solin Marja-Liisa, et al. Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol. 1999;155:1681–1687.10.1016/S0002-9440(10)65483-1
   PubMed Web of Science ®Google Scholar
• Holzman LB, St John PL, Kovari IA, et al. Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int. 1999;56:1481–1491.
   PubMed Web of Science ®Google Scholar
• Tossidou I, Teng B, Menne J, et al. Podocytic PKC-α is regulated in murine and human diabetes and mediates nephrin endocytosis. PLoS ONE. 2010;5:e10185.10.1371/journal.pone.0010185
   PubMed Web of Science ®Google Scholar
• Hayashi D, Ueda S, yamanoue, M, et al. Epigallocatechin-3-gallate activates diacylglycerol kinase alpha via a 67 kDa laminin receptor: a possibility of galloylated catechins as functional food to prevent and/or improve diabetic renal dysfunctions. J Funct Foods. 2015;15:561–569.10.1016/j.jff.2015.04.005
   Web of Science ®Google Scholar
• Kerjaschki D, Ojha PP, Susani M, et al. A beta 1-integrin receptor for fibronectin in human kidney glomeruli. Am J Pathol. 1989;134:481–489.
   PubMed Web of Science ®Google Scholar
• Adler S. Characterization of glomerular epithelial cell matrix receptors. Am J Pathol. 1992;141:571–578.
   PubMed Web of Science ®Google Scholar
• Faul C, Asanuma K, Yanagida-Asanuma E, et al. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 2007;17:428–437.
   PubMed Web of Science ®Google Scholar
• Rainero E, Caswell PT, Muller PA, et al. Diacylglycerol kinase α controls RCP-dependent integrin trafficking to promote invasive migration. J Cell Biol. 2012;196:277–295.10.1083/jcb.201109112
   PubMed Web of Science ®Google Scholar
• Rainero E, Cianflone C, Porporato PE, et al. The diacylglycerol kinase α/Atypical PKC/β1 integrin pathway in SDF-1a mammary carcinoma invasiveness. PLoS ONE. 2014;9:e97144.10.1371/journal.pone.0097144
   PubMed Web of Science ®Google Scholar
• Reeves MB, Andreoli TE. Transforming growth factor b contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA. 2000;97:7667–7669.10.1073/pnas.97.14.7667
   PubMed Web of Science ®Google Scholar
• Cooper ME, Vranes D, Youssef S, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes. 1999;48:2229–2239.10.2337/diabetes.48.11.2229
   PubMed Web of Science ®Google Scholar
• Ziyadeh F, Hoffman BB, Han DC, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti transforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA. 2000;97:8015–8020.10.1073/pnas.120055097
   PubMed Web of Science ®Google Scholar
• de Vriese AS, Tilton RG, Elger M, et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol. 2001;12:993–1000.
   PubMed Web of Science ®Google Scholar
• Tossidou I, Starker G, Kruger J, et al. PKC-alpha modulates TGF-beta signaling and impairs podocyte survival. Cell Physiol Biochem. 2009;24:627–634.10.1159/000257518
   PubMed Web of Science ®Google Scholar
• Hoshi S, Nomoto K, Kuromitsu J, et al. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun. 2002;290:177–184.10.1006/bbrc.2001.6138
   PubMed Web of Science ®Google Scholar
• Giardino I, Edelstein D, Brownlee M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest. 1996;97:1422–1428.10.1172/JCI118563
   PubMed Web of Science ®Google Scholar
• Lee EA, Seo JY, Jiang Z, et al. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 upregulation in mesangial cells and in diabetic kidney. Kidney Int. 2005;67:1762–1771.10.1111/j.1523-1755.2005.00274.x
   PubMed Web of Science ®Google Scholar
• Elbe H, Vardi N, Esrefoglu M, et al. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum Exp Toxico. 2015;34(1):100–113.10.1177/0960327114531995
   PubMed Web of Science ®Google Scholar
• Du X, Matsumura T, Edelstein D, et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest. 2003;112:1049–1057.10.1172/JCI18127
   PubMed Web of Science ®Google Scholar
• Mann JFE, Lonn EM, Yi Q, et al. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE Study. Kidney Int. 2004;65:1375–1380.10.1111/j.1523-1755.2004.00513.x
   PubMed Web of Science ®Google Scholar
• Edgar RM 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37–46.
   PubMed Web of Science ®Google Scholar